Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Oancea, Cristian Iulian
Neptuno, NCT04784559 / 2020-005951-19: Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection	Terminated	3	205	Europe, RoW	Plitidepsin, Dexamethasone, Remdesivir, Favipiravir	PharmaMar	COVID-19 Infection	03/23	03/23
TRECOS, NCT06264674: Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma ().	Active, not recruiting	3	837	Europe, RoW	CHF5993 200/6/12.5 μg pMDI HFA-152a, HFA-152a propellant, Inhaler CHF5993 200/6/12.5 μg pMDI HFA-134a, HFA-134a propellant	Chiesi Farmaceutici S.p.A.	Asthma	07/25	09/25
NCT06767241: Transcranial Non-invasive Electrical Stimulation of the Vagus Nerve in Hospitalized Moderate-to-severe COVID-19 Patients	Completed	N/A	83	Europe	Non-invasive auricular vagus nerve stimulation, Standard Medical Therapy	University of Medicine and Pharmacy "Victor Babes" Timisoara	COVID-19	12/21	03/22

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Oancea, Cristian Iulian
Neptuno, NCT04784559 / 2020-005951-19: Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection	Terminated	3	205	Europe, RoW	Plitidepsin, Dexamethasone, Remdesivir, Favipiravir	PharmaMar	COVID-19 Infection	03/23	03/23
TRECOS, NCT06264674: Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma ().	Active, not recruiting	3	837	Europe, RoW	CHF5993 200/6/12.5 μg pMDI HFA-152a, HFA-152a propellant, Inhaler CHF5993 200/6/12.5 μg pMDI HFA-134a, HFA-134a propellant	Chiesi Farmaceutici S.p.A.	Asthma	07/25	09/25
NCT06767241: Transcranial Non-invasive Electrical Stimulation of the Vagus Nerve in Hospitalized Moderate-to-severe COVID-19 Patients	Completed	N/A	83	Europe	Non-invasive auricular vagus nerve stimulation, Standard Medical Therapy	University of Medicine and Pharmacy "Victor Babes" Timisoara	COVID-19	12/21	03/22